Breast cancer treatment and sulfotransferase

Bibliography

• Henderson BE, Feigelson HS. Hormonal carcinogenesis. Carcinogenesis 2000;21(3):427-33
   PubMed Web of Science ®Google Scholar
• Yager JD, Davidson MD. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006;354(3):270-82
   PubMed Web of Science ®Google Scholar
• Yaghjyan L, Colditz GA. Estrogens in the breast tissue: a systematic review. Cancer Causes Control 2011;22(4):529-40
   Google Scholar
• Hall JM, Couse JF, Korach KS. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 2001;276(40):36869-72
   PubMed Web of Science ®Google Scholar
• Breast and Prostate Cancer Cohort Consortium. Cox DG, Bretsky P, et al. Haplotypes of the estrogen receptor beta gene and breast cancer risk. Int J Cancer 2008;122(2):387-92
   Google Scholar
• Gong H, Guo P, Zhai Y, et al. Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor. Mol Endocrinol 2007;21(8):1781-90
   PubMed Web of Science ®Google Scholar
• Gong H, Jarzynka MJ, Cole TJ, et al. Glucocorticoids antagonize estrogens by glucocorticoid receptor-mediated activation of estrogen sulfotransferase. Cancer Res 2008;68(18):7386-93
   PubMed Web of Science ®Google Scholar
• Xu Y, Liu X, Guo F, et al. Effect of estrogen sulfation by SULT1E1 and PAPSS on the development of estrogen-dependent cancers. Cancer Sci 2012;103(6):1000-9
   Google Scholar
• Strott CA. Sulfonation and molecular action. Endocr Rev 2002;23(5):703-32
   PubMed Web of Science ®Google Scholar
• Lindsay J, Wang LL, Li Y, et al. Structure, function and polymorphism of human cytosolic sulfotransferases. Curr Drug Metab 2008;9(2):99-105
   PubMed Web of Science ®Google Scholar
• Gamage N, Barnett A, Hempel N, et al. Human sulfotransferases and their role in chemical metabolism. Toxicol Sci 2006;90(1):5-22
   PubMed Web of Science ®Google Scholar
• Zhang H, Varlamova O, Vargas FM, et al. Sulfuryl transfer: the catalytic mechanism of human estrogen sulfotransferase. J Biol Chem 1998;273(18):10888-92
   PubMed Web of Science ®Google Scholar
• Falany CN, Krasnykh V, Falany JL. Bacterial expression and characterization of a cDNA for human liver estrogen sulfotransferase. J Steroid Biochem Mol Biol 1995;52(6):529-39
   PubMed Web of Science ®Google Scholar
• Falany JL, Falany CN. Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines. Cancer Res 1996;56(7):1551-5
   PubMed Web of Science ®Google Scholar
• Kohalmy K, Vrzal R. Regulation of phase II biotransformation enzymes by steroid hormones. Curr Drug Metab 2011;12(2):104-23
   PubMed Web of Science ®Google Scholar
• Shang Y. Hormones and cancer. Cell Res 2007;17(4):277-9
   Google Scholar
• Folkerd EJ, Dowsett M. Influence of sex hormones on cancer progression. J Clin Oncol 2010;28(26):4038-44
   PubMed Web of Science ®Google Scholar
• Russo J, Russo IH. The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol 2006;102(1-5):89-96
   PubMed Web of Science ®Google Scholar
• Shang Y. Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis. Nat Rev Cancer 2006;6(5):360-8
   Google Scholar
• Key T, Appleby P, Barnes I, et al. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94(8):606-16
   PubMed Web of Science ®Google Scholar
• Kulendran M, Salhab M, Mokbel K. Oestrogen-synthesising enzymes and breast cancer. Anticancer Res 2009;29(4):1095-109
   Google Scholar
• Auchus ML, Auchus RJ. Human steroid biosynthesis for the oncologist. J Investig Med 2012;60(2):495-503
   Google Scholar
• Thomas C, Gustafsson JA. The different roles of ER subtypes in cancer biology and therapy. Nat Rev Cancer 2011;11(8):597-608
   PubMed Web of Science ®Google Scholar
• Rai D, Frolova A, Frasor J, et al. Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells. Mol Endocrinol 2005;19(6):1606-17
   Google Scholar
• Levin ER. Integration of the extranuclear and nuclear action of estrogen. Mol Endocrinol 2005;19(8):1951-9
   PubMedGoogle Scholar
• Wang C, Liu Y, Cao JM. G protein-coupled receptors: extranuclear mediators for the non-genomic actions of steroids. Int J Mol Sci 2014;15(9):15412-25
   PubMed Web of Science ®Google Scholar
• Vermeulen A, Deslypere JP, Paridaens R, et al. Aromatase, 17 beta-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women. Eur J Cancer Clin Oncol 1986;22(4):515-25
   Google Scholar
• van Landeghem AA, Poortman J, Nabuurs M, et al. Endogenous concentration and subcellular distribution of estrogenes in normal and malignant human breast tissue. Cancer Res 1985;45(6):2900-6
   PubMed Web of Science ®Google Scholar
• Pasqualini JR, Chetrite G, Blacker C, et al. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. J Clin Endocrinol Metab 1996;81(4):1460-4
   PubMed Web of Science ®Google Scholar
• Chetrite GS, Cortes-Prieto J, Philippe JC, et al. Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues. J Steroid Biochem Mol Biol 2000;72(1-2):23-7
   PubMed Web of Science ®Google Scholar
• Geisler J, Detre S, Berntsen H, et al. Influence of neoadjuvant anastrozole (Arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancer. Clin Cancer Res 2001;7(5):1230-6
   PubMed Web of Science ®Google Scholar
• Yue W, Santner SJ, Masamura S, et al. Determinants of tissue estradiol levels and biologic responsiveness in breast tumors. Breast Cancer Res Treat 1998;49(Suppl 1):S1-7; discussion S33-7
   PubMedGoogle Scholar
• Masamura S, Santner SJ, Gimotty P, et al. Mechanism for maintenance of high breast tumor estradiol concentrations in the absence of ovarian function: role of very high affinity tissue uptake. Breast Cancer Res Treat 1997;42(3):215-26
   PubMed Web of Science ®Google Scholar
• Coughtrie MW, Sharp S, Maxwell K, et al. Biology and function of the reversible sulfation pathway catalysed by human sulfotransferases and sulfatases. Chem Biol Interact 1998;109(1-3):3-27
   PubMed Web of Science ®Google Scholar
• Falany CN, Wheeler J, Oh TS, et al. Steroid sulfation by expressed human cytosolic sulfotransferases. J Steroid Biochem Mol Biol 1994;48(4):369-75
   PubMed Web of Science ®Google Scholar
• Falany JL, Azziz R, Falany CN. Identification and characterization of cytosolic sulfotransferases in normal human endometrium. Chem Biol Interact 1998;109(1-3):329-39
   Google Scholar
• Sasano H, Suzuki T, Nakata T, et al. New development in intracrinology of breast carcinoma. Breast Cancer 2006;13(2):129-36
   Google Scholar
• Suzuki T, Nakata T, Miki Y, et al. Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma. Cancer Res 2003;63(11):2762-70
   PubMed Web of Science ®Google Scholar
• Hemmerich S. Carbohydrate sulfotransferases: novel therapeutic targets for inflammation, viral infection and cancer. Drug Discov Today 2001;6(1):27-35
   Google Scholar
• Clarke C, Thorburn P, McDonald D, et al. Enzymic synthesis of steroid sulphates. XV. Structural domains of oestrogen sulphotransferase. Biochim Biophys Acta 1982;707(1):28-37
   Google Scholar
• Pang KS, Schwab AJ, Goresky CA, Chiba M. Transport, binding, and metabolism of sulfate conjugates in the liver. Chem Biol Interact 1994;92(1-3):179-207
   Google Scholar
• Chapman E, Best MD, Hanson SR, et al. Sulfotransferases: structure, mechanism, biological activity, inhibition, and synthetic utility. Angew Chem Int Ed Engl 2004;43(27):3526-48
   PubMed Web of Science ®Google Scholar
• Buirchell BJ, Hähnel R. Metabolism of estradiol-17beta in human endometrium during the menstrual cycle. J Steroid Biochem 1975;6(11-12):1489-94
   Google Scholar
• Markovich D. Physiological roles and regulation of mammalian sulfate transporters. Physiol Rev 2001;81(4):1499-533
   PubMedGoogle Scholar
• Allali-Hassani A, Pan PW, Dombrovski L, et al. Structure and chemical profiling of the human cytosolic sulfotransferases. PLoS Biol 2007;5(5):e97
   PubMed Web of Science ®Google Scholar
• Bojarová P, Williams SJ. Sulfotransferases, sulfatases and formylglycine-generating enzymes: a sulfation fascination. Curr Opin Chem Biol 2008;12(5):573-81
   Google Scholar
• Negishi M, Pedersen LG, Petrotchenko E, et al. Structure and function of sulfotransferases. Arch Biochem Biophys 2001;390(2):149-57
   PubMed Web of Science ®Google Scholar
• Blanchard RL, Freimuth RR, Buck J, et al. A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily. Pharmacogenetics 2004;14(3):199-211
   PubMedGoogle Scholar
• Aksoy IA, Wood TC, Weinshilboum R. Human liver estrogen sulfotransferase: identification by cDNA cloning, expression. Biochem Biophys Res Commun 1994;200(3):1621-9
   PubMed Web of Science ®Google Scholar
• Dooley TP, Haldeman-Cahill R, Joiner J, et al. Expression profiling of human sulfotransferase and sulfatase gene superfamilies in epithelial tissues and cultured cells. Biochem Biophys Res Commun 2000;277(1):236-45
   PubMedGoogle Scholar
• Her C, Aksoy IA, Kimura S, et al. Human estrogen sulfotransferase gene (STE): cloning, structure, and chromosomal localization. Genomics 1995;29(1):16-23
   Google Scholar
• Kotov A, Falany JL, Wang J, et al. Regulation of estrogen activity by sulfation in human Ishikawa endometrial adenocarcinoma cells. J Steroid Biochem Mol Biol 1999;68(3-4):137-44
   Google Scholar
• Kester MH, Bulduk S, van Toor H, et al. Potent inhibition of estrogen sulfotransferase by hydroxylated metabolites of polyhalogenated aromatic hydrocarbons reveals alternative mechanism for estrogenic activity of endocrine disrupters. J Clin Endocrinol Metab 2002;87(3):1142-50
   Google Scholar
• Suiko M, Sakakibara Y, Liu MC. Sulfation of environmental estrogen-like chemicals by human cytosolic sulfotransferases. Biochem Biophys Res Commun 2000;267(1):80-4
   PubMed Web of Science ®Google Scholar
• Petrotchenko EV, Doerflein ME, Kakuta Y, et al. Substrate gating confers steroid specificity to estrogen sulfotransferase. J Biol Chem 1999;274(42):30019-22
   PubMed Web of Science ®Google Scholar
• Duanmu Z, Weckle A, Koukouritaki SB, et al. Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre- and postnatal human liver. J Pharmacol Exp Ther 2006;316(3):1310-17
   PubMed Web of Science ®Google Scholar
• Song WC, Moore R, McLachlan JA, et al. Molecular characterization of a testis-specific estrogen sulfotransferase and aberrant liver expression in obese and diabetogenic C57BL/KsJ-db/db mice. Endocrinology 1995;136(6):2477-84
   PubMed Web of Science ®Google Scholar
• Takase Y, Luu-The V, Poisson Paré D, et al. Expression of sulfotransferase 1E1 in human prostate as studied by in situ hybridization and immunocytochemistry. Prostate 2007;67(4):405-9
   Google Scholar
• Adjei AA, Thomae BA, Prondzinski JL, et al. Human estrogen sulfotransferase (SULT1E1) pharmacogenomics: gene resequencing and functional genomics. Br J Pharmacol 2003;139(8):1373-82
   PubMed Web of Science ®Google Scholar
• Falany JL, Macrina N, Falany CN. Regulation of MCF-7 breast cancer cell growth by beta-estradiol sulfation. Breast Cancer Res Treat 2002;74(2):167-76
   PubMed Web of Science ®Google Scholar
• Her C, Raftogianis R, Weinshilboum RM. Human phenol sulfotransferase STP2 gene: molecular cloning, structural characterization, and chromosomal localization. Genomics 1996;33(3):409-20
   Google Scholar
• Dooley TP, Obermoeller RD, Leiter EH, et al. Mapping of the phenol sulfotransferase gene (STP) to human chromosome 16p12.1-p11.2 and to mouse chromosome 7. Genomics 1993;18(2):440-3
   Google Scholar
• Gaedigk A, Beatty BG, Grant DM. Cloning, structural organization, and chromosomal mapping of the human phenol sulfotransferase STP2 gene. Genomics 1997;40(2):242-6
   Google Scholar
• Falany JL, Lawing L, Falany CN. Identification and characterization of cytosolic sulfotransferase activities in MCF-7 human breast carcinoma cells. J Steroid Biochem Mol Biol 1993;46(4):481-7
   Google Scholar
• Otterness DM, Wieben ED, Wood TC, et al. Human liver dehydroepiandrosterone sulfotransferase: molecular cloning and expression of cDNA. Mol Pharmacol 1992;41(5):865-72
   Google Scholar
• Kong AN, Yang L, Ma M, et al. Molecular cloning of the alcohol/hydroxysteroid form (hSTa) of sulfotransferase from human liver. Biochem Biophys Res Commun 1992;187(1):448-54
   Google Scholar
• Falany CN, Comer KA, Dooley TP, et al. Human dehydroepiandrosterone sulfotransferase. Purification, molecular cloning, and characterization. Ann N Y Acad Sci 1995;774:59-72
   PubMed Web of Science ®Google Scholar
• Meloche CA, Sharma V, Swedmark S, et al. Sulfation of budesonide by human cytosolic sulfotransferase, dehydroepiandrosterone-sulfotransferase (DHEA-ST). Drug Metab Dispos 2002;30(5):582-5
   PubMed Web of Science ®Google Scholar
• Falany JL, Pilloff DE, Leyh TS, et al. Sulfation of raloxifene and 4- hydroxytamoxifen by human cytosolic sulfotransferases. Drug Metab Dispos 2006;34(3):361-8
   PubMed Web of Science ®Google Scholar
• Alnouti Y, Klaassen CD. Regulation of sulfotransferase enzymes by prototypical microsomal enzyme inducers in mice. J Pharmacol Exp Ther 2008;324(2):612-21
   PubMed Web of Science ®Google Scholar
• Runge-Morris M, Kocarek TA, Falany CN. Regulation of the cytosolic sulfotransferases by nuclear receptors. Drug Metab Rev 2013;45(1):15-33
   PubMed Web of Science ®Google Scholar
• Falany CN, He D, Li L, et al. Regulation of hepatic sulfotransferase (SULT) 1E1 expression and effects on estrogenic activity in cystic fibrosis (CF). J Steroid Biochem Mol Biol 2009;114(1-2):113-19
   PubMed Web of Science ®Google Scholar
• Runge-Morris M, Kocarek TA. Regulation of sulfotransferase and UDP-glucuronosyltransferase gene expression by the PPARs. PPAR Res 2009;2009:728941
   PubMed Web of Science ®Google Scholar
• Xu Y, Yang X, Wang Z, et al. Estrogen sulfotransferase (SULT1E1) regulates inflammatory response and lipid metabolism of human endothelial cells via PPARγ. Mol Cell Endocrinol 2013;369(1-2):140-9
   Google Scholar
• Lehmann JM, McKee DD, Watson MA, et al. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 1998;102(5):1016-23
   PubMed Web of Science ®Google Scholar
• Kodama S, Hosseinpour F, Goldstein JA, et al. Liganded pregnane X receptor represses the human sulfotransferase SULT1E1 promoter through disrupting its chromatin structure. Nucleic Acids Res 2011;39(19):8392-403
   PubMed Web of Science ®Google Scholar
• Radovic B, Hussong R, Gerhauser C, et al. Xanthohumol, a prenylated chalcone from hops, modulates hepatic expression of genes involved in thyroid hormone distribution and metabolism. Mol Nutr Food Res 2010;54(Suppl 2):S225-35
   Google Scholar
• Rutgers M, Heusdens FA, Visser TJ. Deiodination of iodothyronine sulfamates by type I iodothyronine deiodinase of rat liver. Endocrinology 1991;129(3):1375-81
   Google Scholar
• Pakharukova M, Smetanina M, Kaledin V, et al. The increased CAR-dependent metabolism of thyroid hormones in mice with high cancer susceptibility. Life Sci 2010;87(13-14):439-44
   Google Scholar
• Savas U, Griffin KJ, Johnson EF. Molecular mechanisms of cytochrome P-450 induction by xenobiotics: an expanded role for nuclear hormone receptors. Mol Pharmacol 1999;56(5):851-7
   PubMed Web of Science ®Google Scholar
• Maglich JM, Stoltz CM, Goodwin B, et al. Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol 2002;62(3):638-46
   PubMed Web of Science ®Google Scholar
• Jetten AM, Kurebayashi S, Ueda E. The ROR nuclear orphan receptor subfamily: critical regulators of multiple biological processes. Prog Nucleic Acid Res Mol Biol 2001;69:205-47
   PubMed Web of Science ®Google Scholar
• Kang HS, Angers M, Beak JY, et al. Gene expression profiling reveals a regulatory role for ROR alpha and ROR gamma in phase I and phase II metabolism. Physiol Genomics 2007;31(2):281-94
   PubMed Web of Science ®Google Scholar
• Pascussi JM, Drocourt L, Fabre JM, et al. Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators. Mol Pharmacol 2000;58(2):361-72
   PubMed Web of Science ®Google Scholar
• Poisson Paré D, Song D, Luu-The V, et al. Expression of estrogen sulfotransferase 1E1 and steroid sulfatase in breast cancer: a immunohistochemical study. Breast Cancer (Auckl) 2009;3:9-21
   Google Scholar
• Pasqualini JR, Gelly C, Lecerf F. Estrogen sulfates: biological and ultrastructural responses and metabolism in MCF-7 human breast cancer cells. Breast Cancer Res Treat 1986;8(3):233-40
   Google Scholar
• Pasqualini JR, Gelly C, Nguyen BL, et al. Importance of estrogen sulfates in breast cancer. J Steroid Biochem 1989;34(1-6):155-63
   PubMedGoogle Scholar
• MacIndoe JH. The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by MCF-7 human breast cancer cells. Endocrinology 1988;123(3):1281-7
   Google Scholar
• Dao TL, Hayes C, Libby PR. Steroid sulfatase activities in human breast tumors. Proc Soc Exp Biol Med 1974;146(2):381-4
   PubMed Web of Science ®Google Scholar
• Vignon F, Terqui M, Westley B, et al. Effects of plasma estrogen sulfates in mammary cancer cells. Endocrinology 1980;106(4):1079-86
   PubMed Web of Science ®Google Scholar
• Nguyen BL, Chetrite G, Pasqualini JR. Transformation of estrone and estradiol in hormone-dependent and hormone-independent human breast cancer cells. Effects of the antiestrogen ICI 164,384, danazol, and promegestone (R-5020). Breast Cancer Res Treat 1995;34(2):139-46
   Google Scholar
• Bonney RC, Reed MJ, Davidson K, et al. The relationship between 17 beta-hydroxysteroid dehydrogenase activity and oestrogen concentrations in human breast tumours and in normal breast tissue. Clin Endocrinol (Oxf) 1983;19(6):727-39
   Google Scholar
• McNeill JM, Reed MJ, Beranek PA, et al. A comparison of the in vivo uptake and metabolism of 3H-oestrone and 3H-oestradiol by normal breast and breast tumour tissues in post-menopausal women. Int J Cancer 1986;38(2):193-6
   Google Scholar
• Miller WR, Forrest AP. Oestradiol synthesis by a human breast carcinoma. Lancet 1974;2(7885):866-8
   Google Scholar
• Abul-Hajj YJ, Iverson R, Kiang DT. Aromatization of androgens by human breast cancer. Steroids 1979;33(2):205-22
   Google Scholar
• Lipton A, Santner SJ, Santen RJ, et al. Aromatase activity in primary and metastatic human breast cancer. Cancer 1987;59(4):779-82
   Google Scholar
• Henke BR, Hever D. Recent advances in estrogen receptor modulators. Curr Opin Drug Discov Devel 2005;8(4):437-48
   Google Scholar
• Nakata T, Takashima S, Shiotsu Y, et al. Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients. J Steroid Biochem Mol Biol 2003;86(3-5):455-60
   Google Scholar
• Brodie AM, Njar VC. Aromatase inhibitors and their application in breast cancer treatment. Steroids 2000:65(4);171-9
   Google Scholar
• Santner SJ, Santen RJ. Inhibition of estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase by antiestrogens. J Steroid Biochem Mol Biol 1993;45(5):383-90
   Google Scholar
• Osborne CK, Shou J, Massarweh S, et al. Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. Clin Cancer Res 2005;11(2 Pt 2):865s-70s
   PubMed Web of Science ®Google Scholar
• Kesmodel SB, Sabnis GJ, Chumsri S, et al. Combined cancer therapy: strategies to overcome acquired aromatase inhibitor resistance. Curr Pharm Des 2014;20(42):6575-83
   Google Scholar
• Malet C, Gompel A, Yaneva H, et al. Estradiol and progesterone receptors in culture normal breast epithelial cells and fibroblasts: immunocytochemical studies. J Clin Endocrinol Metab 1991;73(1):8-17
   Google Scholar
• Hellriegel ET, Matwyshyn GA, Fei P, et al. Regulation of gene expression of various phase I and phase II drug-metabolizing enzymes by tamoxifen in rat liver. Biochem Pharmacol 1996;52(10):1561-8
   Google Scholar
• Nuwaysir EF, Daggett DA, Jordan VC, et al. Phase II enzyme expression in rat liver in response to the antiestrogen tamoxifen. Cancer Res 1996;56(16):3704-10
   Google Scholar
• Segala G, de Medina P, Iuliano L, et al. 5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of tamoxifen in breast cancer cells. Biochem Pharmacol 2013;86(1):175-89
   Google Scholar
• Silvente-Poirot S, Poirot M. Cancer. Cholesterol and cancer, in the balance. Science 2014;343(6178):1445-6
   PubMed Web of Science ®Google Scholar
• Chetrite GS, Paris J, Shields-Botella J, et al. Effect of nomegestrol acetate on human estrogen sulfotransferase activity in the hormone-dependent MCF-7 and T-47D breast cancer cell lines. Anticancer Res 2003;23(6C):4651-6
   Google Scholar
• Chetrite GS, Le Nestour E, Pasqualini JR. Human estrogen sulfotransferase (hEST1) activities and its mRNA in various breast cancer cell lines. Effect of the progestin, promegestone (R-5020). J Steroid Biochem Mol Biol 1998;66(5-6):295-302
   Google Scholar
• Chetrite GS, Ebert C, Wright F, et al. Control of sulfatase and sulfotransferase activities by medrogestone in the hormone-dependent MCF-7 and T-47D human breast cancer cells lines. J Steroid Biochem Mol Biol 1999;70(1-3):39-45
   Google Scholar
• Fischer L, Deppert WR, Pfeifer D, et al. Potential hazards to embryo implantation: a human endometrial in vitro model to identify unwanted antigestagenic actions of chemicals. Toxicol Appl Pharmacol 2012;260(3):232-40
   Google Scholar
• Falany JL, Falany CN. Regulation of SULT1E1 expression in Ishikawa endometrial adenocarcinoma cells by tibolone. Steroids 2006;71(10):880-5
   Google Scholar
• Desreux J, Kloosterboer HJ, Noël A, et al. Effects of tibolone on sulfatase pathway of estrogens metabolism and on growth of MCF-7 human breast tumors implanted in ovariectomized nude mice. Gynecol Obstet Invest 2007;63(1):31-8
   Google Scholar
• Doeren M, Ruebig A, Coelingh Bennink HJ, et al. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. Fertil Steril 2001;75(3):554-9
   Google Scholar
• Chetrite GS, Kloosterboer HJ, Philippe JC, et al. Effect of Org OD14 (LIVIAL) and its metabolites on human estrogen sulphotransferase activity in the hormone-dependent MCF-7 and T-47D, and the hormone-independent MDA-MB-231, breast cancer cell lines. Anticancer Res 1999;19(1A):269-75
   Google Scholar
• Chen Y, Huang C, Zhou T, et al. Biochanin A induction of sulfotransferases in rats. J Biochem Mol Toxicol 2010;24(2):102-14
   Google Scholar
• Chen Y, Huang C, Zhou T, et al. Genistein induction of human sulfotransferases in HepG2 and Caco-2 cells. Basic Clin Pharmacol Toxicol 2008;103(6):553-9
   Google Scholar
• Chen Y, Zhang S, Zhou T, et al. Liver X receptor alpha mediated genistein induction of human dehydroepiandrosterone sulfotransferase (hSULT2A1) in Hep G2 cells. Toxicol Appl Pharmacol 2013;268(2):106-12
   PubMed Web of Science ®Google Scholar
• Hilakivi-Clarke L. Nutritional modulation of terminal end buds: its relevance to breast cancer prevention. Curr Cancer Drug Targets 2007;7(5):465-74
   Google Scholar
• Zhang Y, Kensler TW, Cho CG, et al. Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc Natl Acad Sci USA 1994;91(8):3147-50
   PubMed Web of Science ®Google Scholar
• Zhang Y, Talalay P, Cho CG, et al. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci USA 1992;89(6):2399-403
   PubMed Web of Science ®Google Scholar
• Huang C, Chen Y, Zhou T, et al. Sulfation of dietary flavonoids by human sulfotransferases. Xenobiotica 2009;39(4):312-22
   PubMed Web of Science ®Google Scholar
• Pau TG, Suiko M, Sakakibara Y, et al. Sulfation of flavonoids and other phenolic dietary compounds by the human cytosolic sulfotransferases. Biochem Biophys Res Commun 2001;285(5):1175-9
   Google Scholar
• Otake Y, Nolan AL, Walle UK, et al. Quercetin and resveratrol potently reduce estrogen sulfotransferase activity in normal human mammary epithelial cells. J Steroid Biochem Mol Biol 2000;73(5):265-70
   PubMed Web of Science ®Google Scholar
• Nishimuta H, Ohtani H, Tsujimoto M, et al. Inhibitory effects of various beverages on human recombinant sulfotransferase isoforms SULT1A1 and SULT1A3. Biopharm Drug Dispos 2007;28(9):491-500
   Google Scholar
• Chen X, Baker SM, Chen G. Methotrexate induction of human sulfotransferases in Hep G2 and Caco-2 cells. J Appl Toxicol 2005;25(5):354-60
   Google Scholar
• Wu W, Kocarek TA, Runge-Morris M. Sex-dependent regulation by dexamethasone of murine hydroxysteroid sulfotransferase gene expression. Toxicol Lett 2001;119(3):235-46
   Google Scholar
• Gonzalez A, Cos S, Martinez-Campa C, et al. Selective estrogen enzyme modulator actions of melatonin in human breast cancer cells. J Pineal Res 2008;45(1):86-92
   Google Scholar
• Maiti S, Chen X, Chen G. All-trans retinoic acid induction of sulfotransferases. Basic Clin Pharmacol Toxicol 2005;96(1):44-53
   Google Scholar
• King RS, Ghosh AA, Wu J. Inhibition of human phenol and estrogen sulfotransferase by certain non-steroidal anti-inflammatory agents. Curr Drug Metab 2006;7(7):745-53
   PubMed Web of Science ®Google Scholar
• Kurokawa H, Arteaga CL. ErbB (HER) receptors can abrogate antiestrogen action in human breast cancer by multiple signaling mechanisms. Clin Cancer Res 2003;9(1 Pt 2):511S-5S
   Google Scholar
• Mihaly Z, Sztupinszki Z, Surowiak P, et al. A comprehensive overview of targeted therapy in metastatic renal cell carcinoma. Curr Cancer Drug Targets 2012;12(7):857-72
   PubMed Web of Science ®Google Scholar
• Sawyers C. Targeted cancer therapy. Nature 2004;432(7015):294-7
   PubMed Web of Science ®Google Scholar
• Echchgadda I, Song CS, Oh TS, et al. Gene regulation for the senescence marker protein DHEA-sulfotransferase by the xenobiotic-activated nuclear pregnane X receptor (PXR). Mech Ageing Dev 2004;125(10-11):733-45
   PubMed Web of Science ®Google Scholar